BPA Call HT001415A0002-HT001417F0284

Award Date 9/7/17
Potential Completion Date 9/7/17
Potential Value $112K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price Blanket Purchase Agreement (BPA) call order awarded by the Defense Health Agency to Siemens Healthcare Diagnostics Inc., a for-profit manufacturer of medical testing equipment, reagents, and supplies. The $195,393.93 contract is for the provision of reagents and peripheral consumables in support of the agency's clinical testing capabilities. The award does not have a set-aside designation. Siemens Healthcare Diagnostics Inc. is a subsidiary of the larger parent company...
This federal contract was awarded by the Defense Health Agency (DHA) to Siemens Healthcare Diagnostics Inc., a for-profit manufacturer, for the provision of REAGENTS. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price, with a ceiling value of $500,000.00 and a period of performance ending on September 7, 2017. The contract does not have a set-aside designation. Siemens Healthcare Diagnostics Inc. is the prime contractor, and its parent company is Siemens...
This is a $168,074.36 firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Siemens Healthcare Diagnostics Inc. for the provision of reagents and supplies. The contract has an ultimate completion date of March 31, 2025 and did not utilize any set-aside designations. Siemens Healthcare Diagnostics Inc. is a subsidiary of Siemens Aktiengesellschaft and has secured numerous prime federal contract awards across multiple government agencies for diagnostic laboratory...
This federal contract award to Siemens Healthcare Diagnostics Inc. is for the provision of REAGENTS. The $95,539.89 firm fixed price contract was issued by the Bureau of Medicine and Surgery, which is part of the Department of Defense. The contract is a Blanket Purchase Agreement (BPA) call order with no set-aside designation. Siemens Healthcare Diagnostics Inc. is a for-profit manufacturer of medical testing equipment, reagents, and supplies that has received multiple prior federal contract...
This is a federal contract award to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, by the Defense Health Agency. The contract, valued at $2,752.14, is for the provision of consumable reagents. It is a Blanket Purchase Agreement (BPA) call order with a firm fixed price. The award does not utilize any set-aside designations, indicating Siemens Healthcare Diagnostics Inc. competed for the contract on a full and open basis. Siemens Healthcare Diagnostics Inc. is a...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency to Siemens Healthcare Diagnostics Inc., a subsidiary of Siemens Aktiengesellschaft, to provide clinical chemistry assay reagents. The contract, valued at $57,000.64, has an ultimate completion date of July 31, 2025. Siemens Healthcare Diagnostics Inc. is a manufacturer of in vitro diagnostic solutions and laboratory services that supplies equipment, reagents, consumables, and associated services...
This is a federal contract award to Siemens Healthcare Diagnostics Inc., a wholly-owned subsidiary of Siemens Aktiengesellschaft (Siemens AG), a global technology conglomerate. The contract, with a ceiling value of $99,778.29, was awarded by the Defense Health Agency (DHA) under a Blanket Purchase Agreement (BPA) for the purchase of reagents and related items. The contract is a Firm Fixed Price (FFP) contract with no set-aside designation. Siemens Healthcare Diagnostics Inc. is a major...
This federal contract award was issued by the Defense Health Agency (DHA) to Siemens Healthcare Diagnostics Inc., a for-profit manufacturer, for the provision of reagents, rental equipment, and supplies. The contract has a potential value of $112,519.59 and is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type. The contract does not have a set-aside designation. Siemens Healthcare Diagnostics Inc. is a subsidiary of the larger parent company, Siemens...
This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Siemens Healthcare Diagnostics Inc. to provide reagents and peripheral medical testing equipment. The contract has a ceiling value of $95,000.00 and a performance period ending on September 30, 2015. There was no set-aside used for this award. Siemens Healthcare Diagnostics Inc. is a for-profit manufacturer that has received multiple...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA) for the provision of reagents and peripheral consumables such as Nolan Aponte, AB 3000 21 strip tray, color development pack, enzyme mix 2.0 (LIPA), HCV ampl mix 2.0 (LIPA) ASR, etc. The contract has a ceiling value of $70,000.00 and a period of performance ending on September 30, 2018. The contract was awarded to Siemens Healthcare Diagnostics Inc., a subsidiary of the global technology company...
  • HT001415A0002
    Blanket Purchase Agreement
  • HT001415A0002-HT001417F0284
    BPA Call

This is a firm-fixed-price contract awarded by the Defense Health Agency to Siemens Healthcare Diagnostics Inc., a for-profit manufacturer of medical testing equipment, reagents, and supplies. The contract provides funding for the final invoice #34178732 for the delivery of reagents used for chemical analysis. The contract has a potential value of $112,448.51 and was awarded on September 7, 2017, with a completion date of the same day. The contract was awarded as a Blanket Purchase Agreement (BPA) call and did not utilize any set-aside designations.

Generated 3/23/24, 10:34 PM